The manicogenic properties of clozapine: a rare but serious potential adverse effect.
- Published in:
- Journal of Psychiatry & Neuroscience, 2025, v. 50, n. 3, p. E194, doi. 10.1503/jpn.250048
- By:
- Publication type:
- Article
Works matching DE "CLOZAPINE"
Results: 2956
1
2
The Higher Dose‐Adjusted Clozapine Concentrations in Non‐Smokers With High CRP Levels May Be Associated With the Lower Daily Doses of Clozapine.
- Published in:
- Acta Psychiatrica Scandinavica, 2025, v. 152, n. 2, p. 148, doi. 10.1111/acps.13810
- By:
- Publication type:
- Article
3
Lorazepam challenge test for catatonia.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
4
Clozapine and refractory diabetes treatment.
- Published in:
- Journal of Diabetes Nursing, 2013, v. 17, n. 3, p. 112
- By:
- Publication type:
- Article
5
Klozapine Yanıt veren asperger Bozukluğu ve şizofreni Eştanılı Bir Ergen Olgu.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
6
Eğitim Kurumlari Dışinda Görevli Bir Grup Psikiyatristin Antipsikotik Seçme, Kombine Etme ve Doz Ayarlama Örüntüleri.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2009, v. 19, n. 3, p. 263
- By:
- Publication type:
- Article
7
Clozapine Induced Obsessions Treated with Sertraline in an Adolescent with Schizophrenia.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2009, v. 19, n. 2, p. 155
- By:
- Publication type:
- Article
8
Olanzapine Y ol CII Tardive Discontinuing, Clozapine Ile Treedaisy.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2009, v. 19, p. S262
- By:
- Publication type:
- Article
9
Türkiye'de Klozapin Kullanımı: 2005-2006 Yılları.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2009, v. 19, p. S176
- By:
- Publication type:
- Article
10
Gebe şizofreni Hastasında Klozapin ve EKT Kullanımı: Olgu Sunumu.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
11
Tortikollis Tablosuyla Seyreden Bir Tardiv Distoni Olgusu.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2009, v. 19, p. S130
- By:
- Publication type:
- Article
12
Klozapine Bağlı Retrograd Ejakülasyon Olgusu.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
13
Ketiapin Kullanımı Sırasında Ortaya Çıkan Sinüs Taşikardisi: Üç Olgu Sunumu.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2009, v. 19, n. 1, p. 55
- By:
- Publication type:
- Article
14
Haloperidol veya Klozapin ile Tedavi Edilmekte Olan Şizofrenik Hastalarda Nöropsikolojik Değerlendirme.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2009, v. 19, n. 1, p. 5
- By:
- Publication type:
- Article
15
Arrhythmic Markers and Clozapine in Patients with Schizophrenia: Effect of 10 weeks Clozapine Treatment on Heart Rate Variability, Late Potentials and QT Dispersion.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2008, v. 18, n. 3, p. 167
- By:
- Publication type:
- Article
16
Klozapine Bağlı Siyalorenin Etyolojisi ve Tedavisi.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2007, v. 17, n. 3, p. 147
- By:
- Publication type:
- Article
17
Hastanede Yatan Şizofreni ve Şizoaffektif Bozukluk Tanılı Hastalardaki Antipsikotik Tedavi Seçimlerinin Geriye Dönük Değerlendirilmesi.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2007, v. 17, n. 1, p. 9
- By:
- Publication type:
- Article
18
Şizofrenide Depresif Belirtilerin Önemi ve Psikofarmakolojik Sağaltımı.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2006, v. 16, n. 1, p. 52
- By:
- Publication type:
- Article
19
Çok Erken Başlangıçlı Şzofreni ve Klozapin: Olgu Sunumu.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2006, v. 16, n. 1, p. 47
- By:
- Publication type:
- Article
20
Valproata Ek Olarak Düflük Doz Olanzapin Kullaımına Bağ Şiddetli Ekstrapiramidal Bulgular: Bir Olgu.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2006, v. 16, n. 1, p. 42
- By:
- Publication type:
- Article
21
The effect of taxifolin on oxidative ovarian damage and reproductive dysfunctions induced by antipsychotic drugs in female rats.
- Published in:
- Journal of Obstetrics & Gynaecology Research, 2021, v. 47, n. 6, p. 2140, doi. 10.1111/jog.14769
- By:
- Publication type:
- Article
22
Cohort study suggests benefit of earlier initiation of clozapine.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 5, p. 1, doi. 10.1002/pu.31297
- Publication type:
- Article
23
Study suggests value of including genetic testing in clozapine monitoring.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 4, p. 7, doi. 10.1002/pu.31290
- Publication type:
- Article
24
LAI antipsychotics show effective results in comparative analysis.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 2, p. 3, doi. 10.1002/pu.31263
- Publication type:
- Article
25
Review: Haloperidol, fluphenazine, clozapine show poor results on cognition.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 2, p. 1, doi. 10.1002/pu.31261
- Publication type:
- Article
26
Adults using clozapine have lower relapse rate, more adverse events.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 1, p. 6, doi. 10.1002/pu.31255
- Publication type:
- Article
27
Ileus, pneumonia among most burdensome effects of clozapine treatment.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 1, p. 4, doi. 10.1002/pu.31253
- Publication type:
- Article
28
Oxcarbazepine and clozapine interaction.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 1, p. 2, doi. 10.1002/pu.31251
- By:
- Publication type:
- Article
29
Switch from antipsychotic polypharmacy to monotherapy reduces side effects.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 1, p. 1, doi. 10.1002/pu.31250
- Publication type:
- Article
30
Some anti‐psychotics associated with increased risk of pneumonia.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 10, p. 7, doi. 10.1002/pu.31216
- Publication type:
- Article
31
Study finds increased risk of hematologic malignancy in patients receiving clozapine.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 9, p. 8, doi. 10.1002/pu.31207
- Publication type:
- Article
32
Data on clozapine‐induced agranulocytosis suggest monitoring could be relaxed.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 8, p. 1, doi. 10.1002/pu.31186
- Publication type:
- Article
33
Clozapine‐associated neutropenia infrequent after first 2 years.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 4, p. 7, doi. 10.1002/pu.31145
- Publication type:
- Article
34
LAI added to clozapine reduces risk of hospitalization.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 3, p. 8, doi. 10.1002/pu.31136
- Publication type:
- Article
35
Clozapine is not the end of the story.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 3, p. 7, doi. 10.1002/pu.31134
- By:
- Publication type:
- Article
36
Clozapine‐associated myocarditis.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 2, doi. 10.1002/pu.31107
- By:
- Publication type:
- Article
37
Dose‐related clozapine‐induced weight gain.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 12, p. 2, doi. 10.1002/pu.31095
- By:
- Publication type:
- Article
38
Neutropenia and thyroid dysfunction associated with lithium and clozapine therapy.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 11, p. 2, doi. 10.1002/pu.31084
- By:
- Publication type:
- Article
39
Study: No adverse impact of decreased clozapine monitoring on patient safety.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 8, p. 1, doi. 10.1002/pu.31043
- Publication type:
- Article
40
Study identifies recommended therapeutic levels for clozapine.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 7, p. 4, doi. 10.1002/pu.31036
- Publication type:
- Article
41
Pimavanserin, clozapine improve symptoms of psychosis in patients with Parkinson's disease.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 6, p. 8, doi. 10.1002/pu.31028
- Publication type:
- Article
42
Once‐ versus multiple‐daily dosing of clozapine.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 3, p. 2, doi. 10.1002/pu.30984
- By:
- Publication type:
- Article
43
Potential cinacalcet‐clozapine interaction.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 1, p. 2, doi. 10.1002/pu.30960
- By:
- Publication type:
- Article
44
Clozapine, antipsychotic polytherapy reduce SUD risk in patients with schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 12, p. 1, doi. 10.1002/pu.30947
- Publication type:
- Article
45
Clozapine‐induced polyserositis.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 10, p. 2, doi. 10.1002/pu.30925
- Publication type:
- Article
46
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 9, p. 9, doi. 10.1002/pu.30836
- Publication type:
- Article
47
Study confirms feasibility of clozapine initiation at community level.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 8, p. 3, doi. 10.1002/pu.30901
- Publication type:
- Article
48
Among hospitalized, newer antipsychotics associated with reduced risk of COVID‐19.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 8, p. 1, doi. 10.1002/pu.30898
- Publication type:
- Article
49
Long‐term use of clozapine linked to hematological malignancies.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 7, p. 8, doi. 10.1002/pu.30894
- Publication type:
- Article
50
Prolonged agranulocytosis with clozapine despite colony‐stimulating factor treatment.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 7, p. 2, doi. 10.1002/pu.30889
- Publication type:
- Article